Prudenza nell'uso delle staminali prima conoscere le costituzioni semeiotico-biofisiche.
Non si può non essere d'accordo con la decisione delle Autorità Canadesi circa il rinvio dell'utilizzo delle cellule staminali. Tuttavia i motivi sono anche altri. Ecco la mia e-mail indirizzata al CIHR:
<<I'm an italian retired General Practitioner, since 50 years Researcher in the field of physical semeiotics (See http://www.semeioticabiofisica.it). I've just read a news about your decision, postponing the use of staminal cells untill next June.I agree with you, completely. In addition, there is another paramount reason: according to my theory of Congenital Acidosic Enzyme-Metabolic Histangiopathy, a mitochondrial functional cytopathy, inherited by mother (1-10) (See above-cited site, CAEMH, and Bibliography), we have to consider that nowadays physicians know too little on mytochondria physiology as well as pathology, although I demonstrated - from the clinical viewpoint - that the most common and severe human diseases originate on the base of inherited mitochondrial impairement, the so-called CAEMH (1-10). Before using staminal cells, we must know exactly all donor semeiotic-constitutions and "Real Risks": "What does it means, e.g., treating cancers with the aid of staminal cell of an individual apparently healthy, but really positive for Oncological Terrain "AND" oncological Real Reisk?".
Unfortunately, I cannot write english properly,. Howevere I'm sure you understand what I mean.
References
1) Stagnaro-Neri M., Stagnaro S. Introduzione alla Semeiotica Biofisica. Il Terreno Oncologico. Travel Factory, Roma, 2004. http://www.travelfactory.it/semeiotica_biofisica.htm
2) Stagnaro S., Stagnaro-Neri M., La Melatonina nella Terapia del Terreno Oncologico e del “Reale Rischio” Oncologico. Travel Factory, Roma, 2004. http://www.travelfactory.it/semeiotica_biofisica_2.htm
3) Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico-Biofisiche.Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Travel Factory, Roma, 2004. http://www.travelfactory.it/libro_costituzionisemeiotiche.htm
4) Stagnaro S., Stagnaro-Neri M. Single Patient Based Medicine.La Medicina Basata sul Singolo Paziente: Nuove Indicazioni della Melatonina. Travel Factory, Roma, 2005. http://www.travelfactory.it/libro_singlepatientbased.htm
5) Stagnaro S., Stagnaro-Neri M., Oncological Terrain, conditio sine qua non of Oncogenesis, 2004: http://www.gutjnl.com/cgi/eletters?lookup=by_date&days=60
6) Stagnaro Sergio. Biophysical Semeiotic Constitutions, Genomics, and Cardio-Vascular Diseases. 2004. BMC Cardiovascular Disorders http://www.biomedcentral.com/1471-2261/4/20/comments#95454
7) Stagnaro Sergio. "Genes, Oncological Terrain, and Breast Cancer" World Journal of Surgical Oncology., 2005, http://www.wjso.com/content/3/1/45/comments#205475
8) Stagnaro Sergio. Relevance of Mitochondria in Cancerogenesis. Journal of Carcinogenesis. 2005, 4:1 doi:10.1186/1477-3163-4-1http://www.carcinogenesis.com/content/4/1/1/comments#136454
9) Stagnaro Sergio. Bed-Side Evaluating Breast Cancer Real Risk. World Journal of Surgical Oncology. 2005, 3:67 doi:10.1186/1477-7819-3-67. 2005
10) Stagnaro S., West PJ., Hu FB., Manson JE., Willett WC. Diet and Risk of Type 2 Diabetes. N Engl J Med. 2002 Jan 24;346(4):297-298. [Medline]
I appreciate your comment.
Best regards
Sergio Stagnaro
Riva Trigoso (Genova) Italy
Founder of Biophysical Semeiotics>>>.
|
